ArticleInternational journal of clinical pharmacy2022
Implementation of pharmacist-led deprescribing in collaborative primary care settings.
Article in International journal of clinical pharmacy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Desprescribing antihypertensives in older people in primary care: subgroup analysis of the MINOR randomised clinical trial.International journal of clinical pharmacy · 2025Trial
- Factors related to community pharmacists' intention to provide collaborative deprescribing service for fall-risk medications in older adults: a factorial and theory-based cross-sectional study.International journal of clinical pharmacy · 2026Article
- A qualitative analysis to identify implementation strategies for a deprescribing clinical practice guideline using the CFIR-ERIC Matching Tool: perspectives from consumers and professional stakeholders.International journal of clinical pharmacy · 2026Article
- Reporting patterns of adverse drug withdrawal events using individual case safety reports in the FAERS and Eudravigilance databases.Exploratory research in clinical and social pharmacy · 2026Article
- What Deprescribing Information Should Be Communicated on Discharge and How? A Qualitative Study of Pharmacists' Perspectives on Deprescribing at Transitions of Care.Australasian journal on ageing · 2026Article
- Perspectives on potential pharmacist prescribing in an outpatient dialysis center: qualitative interviews with patients and clinicians.International journal of clinical pharmacy · 2026Article
- Medication Mindfulness: Implementation and Evaluation of a Single-Site, 6-Month Deprescribing Intervention for Patients on Hemodialysis.Kidney360 · 2025Article
- Co-Creation Study Protocol for Developing a Nurse-Led Intervention to Deprescribe Benzodiazepines and Z-Hypnotics in Primary Care Aimed at Empowering Women.Health expectations : an international journal of public participation in health care and health policy · 2025Article
- Exploring Australian pharmacists' experiences with the electronic National Residential Medication Chart: a qualitative descriptive study.International journal of clinical pharmacy · 2025Article
- Insights Into Pharmacist-Led Deprescribing of Benzodiazepines and Related Drugs: A Qualitative Study With Physicians and Pharmacists.Basic & clinical pharmacology & toxicology · 2025Article
- The role of U.S. pharmacists in deprescribing: Recommendations based on a systematic literature review of qualitative studies.Exploratory research in clinical and social pharmacy · 2025Review
- Clinical Integration and Evaluation of the STrategic Optimization of Prescription Medication Use in Patients on HemoDialysis (STOPMed-HD) Intervention.Canadian journal of kidney health and disease · 2025Article
- Deprescribing oral antidiabetics in elderly patients: Do electronic leaflets across the world address it?Exploratory research in clinical and social pharmacy · 2024Article
- Deprescribing NSAIDs: The Potential Role of Community Pharmacists.Pharmacy (Basel, Switzerland) · 2024Article
- What makes a multidisciplinary medication review and deprescribing intervention for older people work well in primary care? A realist review and synthesis.BMC geriatrics · 2023Review
- A Need for Benzodiazepine Deprescribing in the COVID-19 Pandemic: A Cohort Study.Pharmacy (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
In many jurisdictions pharmacists share prescribing responsibilities with other members of the primary care team. Responsibility for deprescribing, the healthcare professional supervised withdrawal of medications that are no longer needed, has not been assumed by a specific member of the primary care team. In this commentary we describe implementation of pharmacist-led deprescribing in collaborative primary care settings using the seven components of knowledge translation. Patient and stakeholder engagement shaped the deprescribing intervention. The intervention was implemented in three collaborative primary care clinics in two Canadian provinces. The evaluation included measures of medication appropriateness, patient satisfaction, and healthcare professional satisfaction. Pharmacist-led deprescribing in primary care was acceptable to both patients and healthcare professionals and demonstrated a reduction of medications deemed to confer more risk than benefit. Our findings support successes in pharmacist-led deprescribing. Future work is needed to understand how to successfully implement and evaluate pharmacist-led deprescribing more widely.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.